Inside these posts: Antitrust

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


Google stock loses shine, back to 2007 price

Google’s stock is exactly where it was in September 2007, and it has fallen 9 percent since Eric Schmidt announced in January that he’d be stepping down as CEO. The problem, investors say, is that for every reason to believe in Google, there seems to be a counterbalancing reason for concern. Get the full story »

Google, ITA deal approved with conditions

The Justice Department approved Google’s purchase of ticketing software company ITA Software as long as ITA’s products remain available to Google’s rivals. Get the full story »

NYSE unswayed by Nasdaq bid

NYSE Euronext believes that any kind of merger with Nasdaq OMX — whether the Big Board were the buyer or the seller — makes little strategic sense, and antitrust regulators would block it, according to a source close to the company.

Abbott must pay $3.5M in Glaxo HIV drug case

From Bloomberg News | A federal jury has ordered Abbott Laboratories to pay drug giant GlaxoSmithKline $3.5 million in damages in an antitrust lawsuit claiming Abbott sought to stifle competition over HIV drugs when it quadrupled the price of its AIDS medicine Norvir in 2003.

N.Y. promises hard look at AT&T/T-Mobile deal

An AT&T store in New York. (Reuters/Brendan McDermid)

AT&T Inc.s $39 billion bid to buy Deutsche Telekom AG’s T-Mobile USA came under scrutiny from New York’s attorney general, who said he is looking into its possible anticompetitive impact.

Citing a potential “near duopoly” as a result of the proposed deal, Atty. Gen. Eric Schneiderman said he wants to ensure the acquisition does not reduce access to low-cost cell phone options. Get the full story »

Glaxo-Abbott case handed to the jury

A jury began deliberating Friday morning on whether Abbott Laboratories should pay GlaxoSmithKline hundreds of millions of dollars over allegations of unfair HIV drug pricing. Get the full story »

Glaxo lawyer: Abbott used HIV drug as weapon

Abbott Laboratories improperly hiked the price of one drug to help it preserve sales growth of one of its other HIV blockbusters, an attorney for GlaxoSmithKline told a jury. Get the full story »

Kraft’s Rosenfeld a no-show in Cadbury probe

Creme Eggs move down the line at the Bournville production plant. (Christopher Furlong/Getty)

Executives from Kraft Foods Inc. appeared at a parliamentary hearing Tuesday over the company’s 11.9 billion-pound acquisition of confectioner Cadbury a year ago, but the absence of Chief Executive Irene Rosenfeld drew criticism from lawmakers.

U.K. lawmakers on the Business, Innovation & Skills committee are discussing with Kraft — maker of Oreo cookies, Philadelphia cream cheese and Maxwell House coffee — the commitments it made a year ago following the takeover, as well as seeking reassurances on jobs and investment into research.

Last April, lawmakers said in a report that Northfield-based Kraft acted “irresponsibly” and “unwisely” during its acquisition of Cadbury and damaged its reputation in the U.K. Get the full story »

Obama chooses CEO group to advise on economy

U.S. President Barack Obama named a group of top corporate executives Wednesday to join a new economic advisory panel, the latest move to boost the economy and reach out to the business community. Get the full story »

Google, EU in antitrust settlement talks

Google and European Union regulators are in tentative talks to resolve an antitrust probe against the Internet’s dominant search engine, a source familiar with the case said Monday.

A deal could avert a lengthy battle and possible fine for the U.S.-based company. Get the full story »

Huawei sues Motorola over technology transfer

Chinese telecommunications company Huawei Technologies Co. sued Motorola and Nokia Siemens Networks Monday, seeking to stop the planned $1.2 billion sale of Motorola’s networks business to the European company.

The lawsuit, filed in U.S. District Court for the Northern District of Illinois, marks the first time Huawei has sued a U.S. company. Get the full story »

DOJ looking into Caterpillar-Bacyrus deal

Bucyrus International Inc. and Caterpillar Inc. received requests from the Department of Justice for additional information regarding the latter’s proposed $7.6 billion acquisition of the mining-equipment company. Get the full story »

Comcast wins FCC approval to take over NBC

The Federal Communications Commission on Tuesday gave Comcast Corp., the country’s largest cable company, the green light to take over NBC Universal, home of the NBC television network.

Four of the commission’s five members voted to let Comcast buy a 51 percent stake in NBC Universal from General Electric Co. for $13.8 billion in cash and assets. Michael Copps, one of the commission’s three Democrats and an opponent of media consolidation, voted against the deal. Get the full story »

Alberto shareholders OK sale to Unilever

Shareholders of Alberto-Culver Co., the maker of  beauty products such as VO5 and Noxzema, have approved the company’s $3.7 billion takeover by  consumer products maker Unilever NV, the companies said on Friday.

The company also said it and Unilever have received a  second request for information from the Department  of Justice, which is reviewing the deal. Get the full story »

Unilever bid for Alberto Culver could be reviewed

From Bloomberg | Unilever’s $3.7 billion takeover of Melrose Park-based Alberto Culver Co. may be reviewed by U.K. antitrust regulators, who said in a statement that they are looking at whether the deal could trigger “a relevant merger situation” and whether it was likely to reduce competition.